Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelin receptor blockade in acute ST-elevation myocardial infarction
2006-006778-11Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of BQ-123 in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Medical University of Vienna. Started Mar 2007; status: completed.
02
Drugs
BQ-123
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2006-006778-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006778-11.